-
1
-
-
0030812331
-
Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers
-
Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F and Caput D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell. 1997; 90(4):809-819.
-
(1997)
Cell.
, vol.90
, Issue.4
, pp. 809-819
-
-
Kaghad, M.1
Bonnet, H.2
Yang, A.3
Creancier, L.4
Biscan, J.C.5
Valent, A.6
Minty, A.7
Chalon, P.8
Lelias, J.M.9
Dumont, X.10
Ferrara, P.11
McKeon, F.12
Caput, D.13
-
2
-
-
0031564954
-
p73 is a simian [correction of human] p53-related protein that can induce apoptosis
-
Jost CA, Marin MC and Kaelin WG, Jr. p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature. 1997; 389(6647):191-194.
-
(1997)
Nature.
, vol.389
, Issue.6647
, pp. 191-194
-
-
Jost, C.A.1
Marin, M.C.2
Kaelin Jr., W.G.3
-
3
-
-
0034685798
-
Induction of neuronal differentiation by p73 in a neuroblastoma cell line
-
De Laurenzi V, Raschella G, Barcaroli D, Annicchiarico-Petruzzelli M, Ranalli M, Catani MV, Tanno B, Costanzo A, Levrero M and Melino G. Induction of neuronal differentiation by p73 in a neuroblastoma cell line. J Biol Chem. 2000; 275(20):15226-15231.
-
(2000)
J Biol Chem.
, vol.275
, Issue.20
, pp. 15226-15231
-
-
De Laurenzi, V.1
Raschella, G.2
Barcaroli, D.3
Annicchiarico-Petruzzelli, M.4
Ranalli, M.5
Catani, M.V.6
Tanno, B.7
Costanzo, A.8
Levrero, M.9
Melino, G.10
-
5
-
-
0036628511
-
Transactivation-deficient DeltaTA-p73 acts as an oncogene
-
Stiewe T, Zimmermann S, Frilling A, Esche H and Putzer BM. Transactivation-deficient DeltaTA-p73 acts as an oncogene. Cancer Res. 2002; 62(13):3598-3602.
-
(2002)
Cancer Res.
, vol.62
, Issue.13
, pp. 3598-3602
-
-
Stiewe, T.1
Zimmermann, S.2
Frilling, A.3
Esche, H.4
Putzer, B.M.5
-
7
-
-
0034899043
-
Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemia
-
Novak U, Grob TJ, Baskaynak G, Peters UR, Aebi S, Zwahlen D, Tschan MP, Kreuzer KA, Leibundgut EO, Cajot JF, Tobler A and Fey MF. Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemia. Ann Oncol. 2001; 12(7):981-986.
-
(2001)
Ann Oncol.
, vol.12
, Issue.7
, pp. 981-986
-
-
Novak, U.1
Grob, T.J.2
Baskaynak, G.3
Peters, U.R.4
Aebi, S.5
Zwahlen, D.6
Tschan, M.P.7
Kreuzer, K.A.8
Leibundgut, E.O.9
Cajot, J.F.10
Tobler, A.11
Fey, M.F.12
-
8
-
-
0344441928
-
DeltaNp73 can modulate the expression of various genes in a p53-independent fashion
-
Kartasheva NN, Lenz-Bauer C, Hartmann O, Schafer H, Eilers M and Dobbelstein M. DeltaNp73 can modulate the expression of various genes in a p53-independent fashion. Oncogene. 2003; 22(51):8246-8254.
-
(2003)
Oncogene.
, vol.22
, Issue.51
, pp. 8246-8254
-
-
Kartasheva, N.N.1
Lenz-Bauer, C.2
Hartmann, O.3
Schafer, H.4
Eilers, M.5
Dobbelstein, M.6
-
9
-
-
0346725958
-
DeltaNp73beta is active in transactivation and growth suppression
-
Liu G, Nozell S, Xiao H and Chen X. DeltaNp73beta is active in transactivation and growth suppression. Mol Cell Biol. 2004; 24(2):487-501.
-
(2004)
Mol Cell Biol.
, vol.24
, Issue.2
, pp. 487-501
-
-
Liu, G.1
Nozell, S.2
Xiao, H.3
Chen, X.4
-
10
-
-
41649120554
-
DeltaNp73alpha regulates MDR1 expression by inhibiting p53 function
-
Vilgelm A, Wei JX, Piazuelo MB, Washington MK, Prassolov V, El-Rifai W and Zaika A. DeltaNp73alpha regulates MDR1 expression by inhibiting p53 function. Oncogene. 2008; 27(15):2170-2176.
-
(2008)
Oncogene.
, vol.27
, Issue.15
, pp. 2170-2176
-
-
Vilgelm, A.1
Wei, J.X.2
Piazuelo, M.B.3
Washington, M.K.4
Prassolov, V.5
El-Rifai, W.6
Zaika, A.7
-
11
-
-
53549134949
-
TAp73 knockout shows genomic instability with infertility and tumor suppressor functions
-
Tomasini R, Tsuchihara K, Wilhelm M, Fujitani M, Rufini A, Cheung CC, Khan F, Itie-Youten A, Wakeham A, Tsao MS, Iovanna JL, Squire J, Jurisica I, Kaplan D, Melino G, Jurisicova A, et al. TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev. 2008; 22(19):2677-2691.
-
(2008)
Genes Dev.
, vol.22
, Issue.19
, pp. 2677-2691
-
-
Tomasini, R.1
Tsuchihara, K.2
Wilhelm, M.3
Fujitani, M.4
Rufini, A.5
Cheung, C.C.6
Khan, F.7
Itie-Youten, A.8
Wakeham, A.9
Tsao, M.S.10
Iovanna, J.L.11
Squire, J.12
Jurisica, I.13
Kaplan, D.14
Melino, G.15
Jurisicova, A.16
-
12
-
-
77949362925
-
Isoform-specific p73 knockout mice reveal a novel role for delta Np73 in the DNA damage response pathway
-
Wilhelm MT, Rufini A, Wetzel MK, Tsuchihara K, Inoue S, Tomasini R, Itie-Youten A, Wakeham A, Arsenian-Henriksson M, Melino G, Kaplan DR, Miller FD and Mak TW. Isoform-specific p73 knockout mice reveal a novel role for delta Np73 in the DNA damage response pathway. Genes Dev. 2010; 24(6):549-560.
-
(2010)
Genes Dev.
, vol.24
, Issue.6
, pp. 549-560
-
-
Wilhelm, M.T.1
Rufini, A.2
Wetzel, M.K.3
Tsuchihara, K.4
Inoue, S.5
Tomasini, R.6
Itie-Youten, A.7
Wakeham, A.8
Arsenian-Henriksson, M.9
Melino, G.10
Kaplan, D.R.11
Miller, F.D.12
Mak, T.W.13
-
13
-
-
84863307217
-
Relative expression of TAp73 and DeltaNp73 isoforms
-
Conforti F, Yang AL, Agostini M, Rufini A, Tucci P, Nicklison-Chirou MV, Grespi F, Velletri T, Knight RA, Melino G and Sayan BS. Relative expression of TAp73 and DeltaNp73 isoforms. Aging (Albany NY). 2012; 4(3):202-205.
-
(2012)
Aging (Albany NY).
, vol.4
, Issue.3
, pp. 202-205
-
-
Conforti, F.1
Yang, A.L.2
Agostini, M.3
Rufini, A.4
Tucci, P.5
Nicklison-Chirou, M.V.6
Grespi, F.7
Velletri, T.8
Knight, R.A.9
Melino, G.10
Sayan, B.S.11
-
14
-
-
21744451041
-
Effects of inducible overexpression of DNp73alpha on cancer cell growth and response to treatment in vitro and in vivo
-
Marabese M, Marchini S, Sabatino MA, Polato F, Vikhanskaya F, Marrazzo E, Riccardi E, Scanziani E and Broggini M. Effects of inducible overexpression of DNp73alpha on cancer cell growth and response to treatment in vitro and in vivo. Cell Death Differ. 2005; 12(7):805-814.
-
(2005)
Cell Death Differ.
, vol.12
, Issue.7
, pp. 805-814
-
-
Marabese, M.1
Marchini, S.2
Sabatino, M.A.3
Polato, F.4
Vikhanskaya, F.5
Marrazzo, E.6
Riccardi, E.7
Scanziani, E.8
Broggini, M.9
-
15
-
-
59449095912
-
TAp73alpha binds the kinetochore proteins Bub1 and Bub3 resulting in polyploidy
-
Vernole P, Neale MH, Barcaroli D, Munarriz E, Knight RA, Tomasini R, Mak TW, Melino G and De Laurenzi V. TAp73alpha binds the kinetochore proteins Bub1 and Bub3 resulting in polyploidy. Cell Cycle. 2009; 8(3):421-429.
-
(2009)
Cell Cycle.
, vol.8
, Issue.3
, pp. 421-429
-
-
Vernole, P.1
Neale, M.H.2
Barcaroli, D.3
Munarriz, E.4
Knight, R.A.5
Tomasini, R.6
Mak, T.W.7
Melino, G.8
De Laurenzi, V.9
-
16
-
-
84893809386
-
Ectopic expression of p73a but not p73{beta} suppresses myogenic differentiation
-
Li CY, Zhu J and Wang JY. Ectopic expression of p73a but not p73{beta} suppresses myogenic differentiation. J Biol Chem. 2004; 14:14.
-
(2004)
J Biol Chem.
, vol.14
, pp. 14
-
-
Li, C.Y.1
Zhu, J.2
Wang, J.Y.3
-
17
-
-
26644455289
-
Full-length p73alpha represses drug-induced apoptosis in small cell lung carcinoma cells
-
Epub 32005 Aug 34158
-
Nyman U, Sobczak-Pluta A, Vlachos P, Perlmann T, Zhivotovsky B and Joseph B. Full-length p73alpha represses drug-induced apoptosis in small cell lung carcinoma cells. J Biol Chem. 2005; 280(40):34159-34169. Epub 32005 Aug 34158.
-
(2005)
J Biol Chem.
, vol.280
, Issue.40
, pp. 34159-34169
-
-
Nyman, U.1
Sobczak-Pluta, A.2
Vlachos, P.3
Perlmann, T.4
Zhivotovsky, B.5
Joseph, B.6
-
18
-
-
84863008665
-
TAp73alpha protects small cell lung carcinoma cells from caspase-2 induced mitochondrial mediated apoptotic cell death
-
Muppani N, Nyman U and Joseph B. TAp73alpha protects small cell lung carcinoma cells from caspase-2 induced mitochondrial mediated apoptotic cell death. Oncotarget. 2011; 2(12):1145-1154.
-
(2011)
Oncotarget.
, vol.2
, Issue.12
, pp. 1145-1154
-
-
Muppani, N.1
Nyman, U.2
Joseph, B.3
-
19
-
-
79960302146
-
Hsp72 mediates TAp73alpha anti-apoptotic effects in small cell lung carcinoma cells
-
Nyman U, Muppani NR, Zhivotovsky B and Joseph B. Hsp72 mediates TAp73alpha anti-apoptotic effects in small cell lung carcinoma cells. J Cell Mol Med. 2011;15(8):1757-1768.
-
(2011)
J Cell Mol Med.
, vol.15
, Issue.8
, pp. 1757-1768
-
-
Nyman, U.1
Muppani, N.R.2
Zhivotovsky, B.3
Joseph, B.4
-
20
-
-
0034745717
-
P73a overexpression is associated with resistance to treatment with DNA-damaging agents in a human ovarian cancer cell line
-
Vikhanskaya F, Marchini S, Marabese M, Galliera E and Broggini M. P73a overexpression is associated with resistance to treatment with DNA-damaging agents in a human ovarian cancer cell line. Cancer Res. 2001; 61(3):935-938.
-
(2001)
Cancer Res.
, vol.61
, Issue.3
, pp. 935-938
-
-
Vikhanskaya, F.1
Marchini, S.2
Marabese, M.3
Galliera, E.4
Broggini, M.5
-
21
-
-
79952284127
-
Hallmarks of cancer: the next generation
-
Hanahan D and Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-674.
-
(2011)
Cell.
, vol.144
, Issue.5
, pp. 646-674
-
-
Hanahan, D.1
Weinberg, R.A.2
-
22
-
-
0038481970
-
The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited
-
Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer. 2003; 3(6):453-458.
-
(2003)
Nat Rev Cancer.
, vol.3
, Issue.6
, pp. 453-458
-
-
Fidler, I.J.1
-
23
-
-
0041345735
-
Tumor suppressor p53 and its homologue p73alpha affect cell migration
-
Sablina AA, Chumakov PM and Kopnin BP. Tumor suppressor p53 and its homologue p73alpha affect cell migration. J Biol Chem. 2003; 278(30):27362-27371.
-
(2003)
J Biol Chem.
, vol.278
, Issue.30
, pp. 27362-27371
-
-
Sablina, A.A.1
Chumakov, P.M.2
Kopnin, B.P.3
-
24
-
-
84893802597
-
The Cdk inhibitor p57(Kip2) controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamics
-
Vlachos P and Joseph B. The Cdk inhibitor p57(Kip2) controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamics. Oncogene. 2009; 7:7.
-
(2009)
Oncogene.
, vol.7
, pp. 7
-
-
Vlachos, P.1
Joseph, B.2
-
26
-
-
0037133639
-
Induction of p57(KIP2) expression by p73beta
-
Blint E, Phillips AC, Kozlov S, Stewart CL and Vousden KH. Induction of p57(KIP2) expression by p73beta. Proc Natl Acad Sci U S A. 2002; 99(6):3529-3534.
-
(2002)
Proc Natl Acad Sci U S A.
, vol.99
, Issue.6
, pp. 3529-3534
-
-
Blint, E.1
Phillips, A.C.2
Kozlov, S.3
Stewart, C.L.4
Vousden, K.H.5
-
27
-
-
16844370831
-
p73beta-Mediated apoptosis requires p57kip2 induction and IEX-1 inhibition
-
Gonzalez S, Perez-Perez MM, Hernando E, Serrano M and Cordon-Cardo C. p73beta-Mediated apoptosis requires p57kip2 induction and IEX-1 inhibition. Cancer Res. 2005; 65(6):2186-2192.
-
(2005)
Cancer Res.
, vol.65
, Issue.6
, pp. 2186-2192
-
-
Gonzalez, S.1
Perez-Perez, M.M.2
Hernando, E.3
Serrano, M.4
Cordon-Cardo, C.5
-
28
-
-
24044476212
-
A role of p73 in mitotic exit
-
Merlo P, Fulco M, Costanzo A, Mangiacasale R, Strano S, Blandino G, Taya Y, Lavia P and Levrero M. A role of p73 in mitotic exit. J Biol Chem. 2005; 280(34):30354-30360.
-
(2005)
J Biol Chem.
, vol.280
, Issue.34
, pp. 30354-30360
-
-
Merlo, P.1
Fulco, M.2
Costanzo, A.3
Mangiacasale, R.4
Strano, S.5
Blandino, G.6
Taya, Y.7
Lavia, P.8
Levrero, M.9
-
29
-
-
0035951352
-
Aquaporin 3, a glycerol and water transporter, is regulated by p73 of the p53 family
-
Zheng X and Chen X. Aquaporin 3, a glycerol and water transporter, is regulated by p73 of the p53 family. FEBS Lett. 2001; 489(1):4-7.
-
(2001)
FEBS Lett.
, vol.489
, Issue.1
, pp. 4-7
-
-
Zheng, X.1
Chen, X.2
-
30
-
-
79953840789
-
The hallmarks of CDKN1C (p57, KIP2) in cancer
-
Kavanagh E and Joseph B. The hallmarks of CDKN1C (p57, KIP2) in cancer. Biochim Biophys Acta. 2011; 1816(1):50-56.
-
(2011)
Biochim Biophys Acta.
, vol.1816
, Issue.1
, pp. 50-56
-
-
Kavanagh, E.1
Joseph, B.2
-
31
-
-
69049120164
-
p57Kip2 is a repressor of Mash1 activity and neuronal differentiation in neural stem cells
-
Joseph B, Andersson ER, Vlachos P, Sodersten E, Liu L, Teixeira AI and Hermanson O. p57Kip2 is a repressor of Mash1 activity and neuronal differentiation in neural stem cells. Cell Death Differ. 2009; 16(9):1256-1265.
-
(2009)
Cell Death Differ.
, vol.16
, Issue.9
, pp. 1256-1265
-
-
Joseph, B.1
Andersson, E.R.2
Vlachos, P.3
Sodersten, E.4
Liu, L.5
Teixeira, A.I.6
Hermanson, O.7
-
32
-
-
0346103669
-
p57(Kip2) cooperates with Nurr1 in developing dopamine cells
-
Joseph B, Wallen-Mackenzie A, Benoit G, Murata T, Okret S and Perlmann T. p57(Kip2) cooperates with Nurr1 in developing dopamine cells. Proc Natl Acad Sci U S A. 2003; 100(26):15619-15624.
-
(2003)
Proc Natl Acad Sci U S A.
, vol.100
, Issue.26
, pp. 15619-15624
-
-
Joseph, B.1
Wallen-Mackenzie, A.2
Benoit, G.3
Murata, T.4
Okret, S.5
Perlmann, T.6
-
33
-
-
34447644950
-
The cell cycle inhibitor p57(Kip2) promotes cell death via the mitochondrial apoptotic pathway
-
Vlachos P, Nyman U, Hajji N and Joseph B. The cell cycle inhibitor p57(Kip2) promotes cell death via the mitochondrial apoptotic pathway. Cell Death Differ. 2007; 14(8):1497-1507.
-
(2007)
Cell Death Differ.
, vol.14
, Issue.8
, pp. 1497-1507
-
-
Vlachos, P.1
Nyman, U.2
Hajji, N.3
Joseph, B.4
-
34
-
-
84861556769
-
p57(KIP2) control of actin cytoskeleton dynamics is responsible for its mitochondrial pro-apoptotic effect
-
Kavanagh E, Vlachos P, Emourgeon V, Rodhe J and Joseph B. p57(KIP2) control of actin cytoskeleton dynamics is responsible for its mitochondrial pro-apoptotic effect. Cell Death Dis. 2012; 3:e311.
-
(2012)
Cell Death Dis.
, vol.3
-
-
Kavanagh, E.1
Vlachos, P.2
Emourgeon, V.3
Rodhe, J.4
Joseph, B.5
-
35
-
-
42449103052
-
Sp1-like sequences mediate human caspase-3 promoter activation by p73 and cisplatin
-
Sudhakar C, Jain N and Swarup G. Sp1-like sequences mediate human caspase-3 promoter activation by p73 and cisplatin. FEBS J. 2008; 275(9):2200-2213.
-
(2008)
FEBS J.
, vol.275
, Issue.9
, pp. 2200-2213
-
-
Sudhakar, C.1
Jain, N.2
Swarup, G.3
-
36
-
-
33749433216
-
p53 family members in myogenic differentiation and rhabdomyosarcoma development
-
Cam H, Griesmann H, Beitzinger M, Hofmann L, Beinoraviciute-Kellner R, Sauer M, Huttinger-Kirchhof N, Oswald C, Friedl P, Gattenlohner S, Burek C, Rosenwald A and Stiewe T. p53 family members in myogenic differentiation and rhabdomyosarcoma development. Cancer Cell. 2006; 10(4):281-293.
-
(2006)
Cancer Cell.
, vol.10
, Issue.4
, pp. 281-293
-
-
Cam, H.1
Griesmann, H.2
Beitzinger, M.3
Hofmann, L.4
Beinoraviciute-Kellner, R.5
Sauer, M.6
Huttinger-Kirchhof, N.7
Oswald, C.8
Friedl, P.9
Gattenlohner, S.10
Burek, C.11
Rosenwald, A.12
Stiewe, T.13
-
37
-
-
0035966345
-
p53, p63 and p73--solos, alliances and feuds among family members
-
Moll UM, Erster S and Zaika A. p53, p63 and p73--solos, alliances and feuds among family members. Biochim Biophys Acta. 2001; 1552(2):47-59.
-
(2001)
Biochim Biophys Acta.
, vol.1552
, Issue.2
, pp. 47-59
-
-
Moll, U.M.1
Erster, S.2
Zaika, A.3
-
38
-
-
0032533514
-
The potential tumor suppressor p73 differentially regulates cellular p53 target genes
-
Zhu J, Jiang J, Zhou W and Chen X. The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res. 1998; 58(22):5061-5065.
-
(1998)
Cancer Res.
, vol.58
, Issue.22
, pp. 5061-5065
-
-
Zhu, J.1
Jiang, J.2
Zhou, W.3
Chen, X.4
-
39
-
-
0033595124
-
Promoter specificity and stability control of the p53-related protein p73
-
Lee CW and La Thangue NB. Promoter specificity and stability control of the p53-related protein p73. Oncogene. 1999; 18(29):4171-4181.
-
(1999)
Oncogene.
, vol.18
, Issue.29
, pp. 4171-4181
-
-
Lee, C.W.1
La Thangue, N.B.2
-
40
-
-
0036125352
-
Role of p73 in malignancy: tumor suppressor or oncogene?
-
Stiewe T and Putzer BM. Role of p73 in malignancy: tumor suppressor or oncogene? Cell Death Differ. 2002; 9(3):237-245.
-
(2002)
Cell Death Differ
, vol.9
, Issue.3
, pp. 237-245
-
-
Stiewe, T.1
Putzer, B.M.2
-
41
-
-
36349022052
-
p73 expression in medulloblastoma: TAp73/DeltaNp73 transcript detection and possible association of p73alpha/DeltaNp73 immunoreactivity with survival
-
Zitterbart K, Zavrelova I, Kadlecova J, Spesna R, Kratochvilova A, Pavelka Z and Sterba J. p73 expression in medulloblastoma: TAp73/DeltaNp73 transcript detection and possible association of p73alpha/DeltaNp73 immunoreactivity with survival. Acta Neuropathol. 2007; 114(6):641-650.
-
(2007)
Acta Neuropathol.
, vol.114
, Issue.6
, pp. 641-650
-
-
Zitterbart, K.1
Zavrelova, I.2
Kadlecova, J.3
Spesna, R.4
Kratochvilova, A.5
Pavelka, Z.6
Sterba, J.7
-
42
-
-
84859865843
-
p53 Family: Role of Protein Isoforms in Human Cancer
-
Wei J, Zaika E and Zaika A. p53 Family: Role of Protein Isoforms in Human Cancer. J Nucleic Acids. 2012; 2012:687359.
-
(2012)
J Nucleic Acids.
, vol.2012
, pp. 687359
-
-
Wei, J.1
Zaika, E.2
Zaika, A.3
-
43
-
-
0037897280
-
Expression of p73 and c-Abl proteins in human ovarian carcinomas
-
Niyazi M, Ghazizadeh M, Konishi H, Kawanami O, Sugisaki Y and Araki T. Expression of p73 and c-Abl proteins in human ovarian carcinomas. J Nippon Med Sch. 2003; 70(3):234-242.
-
(2003)
J Nippon Med Sch.
, vol.70
, Issue.3
, pp. 234-242
-
-
Niyazi, M.1
Ghazizadeh, M.2
Konishi, H.3
Kawanami, O.4
Sugisaki, Y.5
Araki, T.6
-
44
-
-
0034112090
-
Loss of imprinting and elevated expression of wild-type p73 in human gastric adenocarcinoma
-
Kang MJ, Park BJ, Byun DS, Park JI, Kim HJ, Park JH and Chi SG. Loss of imprinting and elevated expression of wild-type p73 in human gastric adenocarcinoma. Clin Cancer Res. 2000; 6(5):1767-1771.
-
(2000)
Clin Cancer Res.
, vol.6
, Issue.5
, pp. 1767-1771
-
-
Kang, M.J.1
Park, B.J.2
Byun, D.S.3
Park, J.I.4
Kim, H.J.5
Park, J.H.6
Chi, S.G.7
-
45
-
-
0033602251
-
Overexpression of the wild type p73 gene in human bladder cancer
-
Yokomizo A, Mai M, Tindall DJ, Cheng L, Bostwick DG, Naito S, Smith DI and Liu W. Overexpression of the wild type p73 gene in human bladder cancer. Oncogene. 1999; 18(8):1629-1633.
-
(1999)
Oncogene.
, vol.18
, Issue.8
, pp. 1629-1633
-
-
Yokomizo, A.1
Mai, M.2
Tindall, D.J.3
Cheng, L.4
Bostwick, D.G.5
Naito, S.6
Smith, D.I.7
Liu, W.8
-
46
-
-
16544383365
-
Deregulation of p73 isoform equilibrium in benign prostate hyperplasia and prostate cancer
-
Arvanitis DA, Lianos E, Soulitzis N, Delakas D and Spandidos DA. Deregulation of p73 isoform equilibrium in benign prostate hyperplasia and prostate cancer. Oncol Rep. 2004; 12(5):1131-1137.
-
(2004)
Oncol Rep.
, vol.12
, Issue.5
, pp. 1131-1137
-
-
Arvanitis, D.A.1
Lianos, E.2
Soulitzis, N.3
Delakas, D.4
Spandidos, D.A.5
-
47
-
-
0141508002
-
p73 tumor-suppressor activity is impaired in human thyroid cancer
-
Frasca F, Vella V, Aloisi A, Mandarino A, Mazzon E, Vigneri R and Vigneri P. p73 tumor-suppressor activity is impaired in human thyroid cancer. Cancer Res. 2003; 63(18):5829-5837.
-
(2003)
Cancer Res.
, vol.63
, Issue.18
, pp. 5829-5837
-
-
Frasca, F.1
Vella, V.2
Aloisi, A.3
Mandarino, A.4
Mazzon, E.5
Vigneri, R.6
Vigneri, P.7
|